| PRODUCT DESCRIPTION |
| PHARMACEUTICAL FORMULATIONS-DYNAPAR AQ 1ML (DICLOFENAC SODIUM INJECTION-75 MG/ML-1ML) (1 AMPOULE)(PHYSICIAN SAMPLES) |
| PHARMACEUTICAL FORMULATIONS-DYNAPAR AQ 1ML (DICLOFENAC SODIUM INJECTION-75 MG/ML-1ML) (1 AMPOULE) |
| ASPIRIN DELAYED RELEASE TABLETS USP 81 MG (49 PACK = 9604 TABLETS) (NO COMMERCIAL VALUE) |
| PLACEBO ASPIRIN DELAYED RELEASE TABLETSUSP 81 MG (50 PACK = 9800 TABLETS) (NO COMMERCIAL VALUE) |
| FREE SAMPLE OF NCV(RS.5000/-):KAMAGRA TABLETS 100MG [450 PACK X 1 X 4 = 1800 TABS][EACH TABS CONT:AS PER INVOICE |
| WE INTEND TO CLAIM REWARDS UNDER MERCHANDISE EXPORTS FROM INDIA SCHEME (MEIS) |
| I/WE UNDERTAKE TO ABIDE BY THE PROVISIONS OF FOREIGN EXCHANGE MANAGEMENT ACT,1999,AS AMENDED FROM TIME TO TIME."INCLUDIN |
| KAMAGRA TABLETS 100MG [3000 PACK X 1 X 4= 12000 TABS][EACH TABS CONT: SILDENAFIL CITRATE 100MG] |
| 9016 NOS PHY. SPLS. FREE OF CHARGE VALUE FOR CUSTOM PURPOSE RS. 327161/- |
| WE INTEND TO CLAIM REWARDS UNDER MERCHANDISE EXPORTS FROM INDIA SCHEME (MEIS) |
| 384 NOS PROM. GOODS .(KELVIN-P SYRUP BP 60 ML) FREE OF CHARGE VALUE FOR CUSTOM PURPOSE RS.5411/- |
| PHARMACEUTICALS MEDICINES PIRFENIDONE TABLETS |
| PHARMACEUTICALS MEDICINES HYALURONIC ACID INJECTION |
| PHARMACEUTICALS MEDICINES BOSENTAN 62.5MG |
| PHARMACEUTICALS MEDICINES LENALIDOMIDE CAPSULES |
| PHARMACEUTICALS MEDICINES LENALIDOMIDE CAPSULES |
| PHARMACEUTICALS MEDICINES CHOLECALCIFEROL GRANULES |
| PHARMACEUTICALS MEDICINES VITAMINE D3 INJ. |
| PHARMACEUTICALS MEDICINES SORAFENIB TABLETS |
| PHARMACEUTICALS MEDICINES BORTEZOMIB 3.5MG |
| PHARMACEUTICALS MEDICINES HYALURONIC ACID INJECTION |
| PHARMACEUTICALS MEDICINES SORAFENIB TABLETS |
| MEDICAL SUPPLIES - OCEMAX 200 DT (CEFIXIME 200 MG DISPERDIBLE) USP TABLETS |
| PENODEX OINTMENT 20 G.REGN NO. 112/07 B.NO. 107MFG DT: 10-2016, EXP DT: 09-2019 |
| NO SCAR CREAM 20 GM.REGN NO. 088/07 B.NO. 38MFG.DT: 09-2016, EXP DT: 08-2019 |
| AMBRODIL SYRUP (3000X100ML) AMBROXOL HYDROCHLORIDE SYRUP |
| ARISTOZYME LIQUID (500X200ML) PEPSIN ANDDIASTASE LIQUID |
| ARISTOZYME LIQUID (50X200ML) N.C.V. PEPSIN AND DIASTASE LIQUID |
| GRAZINE TABLETS (CETIRIZINE DIHYDROCHLORIDE TABLETS 10 MG)(10000X10X10 TABS |
| AMBRODIL SYRUP (300X100ML) N.C.V. AMBROXOL HYDROCHLORIDE SYRUP |
| PHARMACEUTICAL PRODUCTS:-GALAXY S ATRACURIUM (ATRACURIUM BESYLATE INJECTION 10MG/ ML, 5 ML) |
| DIAPRIDE PLUS TABLETS (GLIMEPIRIDE 1MG+SUSTAINED RELEASE METFOR HYDROCHLORIDE 500MG TABLETS) (3X10S) ORAL HYPOGLYCEMIC A |
| DIAPRIDE PLUS (GLIMEPIRIDE 1MG+SUSTAINEDRELEASE METFOR HYDROCHLORIDE 500MG TABLETS ) (3X10S) ORAL HYPOGLYCEMIC AGENTS |
| DIAPRIDE PLUS (GLIMEPIRIDE 1MG+SUSTAINED RELEASE METFOR HYDROCHLORIDE 500MG TABLETS) (3X10S) ORAL HYPOGLYCEMIC AGENTS |
| HAEMO FORTE SYRUP [1X200 ML] EACH 100MLCONT: AS PER INVOICE |
| HAEMO FORTE SYRUP [1X90 ML] EACH 100MLCONT: AS PER INVOICE |
| DIAPRIDE PLUS (GLIMEPIRIDE 1MG+SUSTAINED RELEASE METFOR HYDROCHLORIDE 500MG TABLETS) (3X10S) ORAL HYPOGLYCEMIC AGENTS |
| PHARMACEUTICALS DRUGS & MEDICINES : NEUROGAME TABLET (GABAPENTIN AND METHYLCOBALAMINE TABLETS) |
| WE INTEND TO CLAIM REWARDS UNDER MERCHANDISE EXPORTS FROM INDIA SCHEME(MEIS |
| NUGREL (CLOPIDOGREL BISULPHATE TABS 75MG) (3X10S) ANTI-THROMBOTICS ( WE INTENDTO CLAIM REWARDS UNDER MEIS SCHEME ) ( F |
| DIAPRIDE PLUS (GLIMEPIRIDE 1MG+SUSTAINED RELEASE METFOR HYDROCHLORIDE 500MG TABLETS) (3X10S) ORAL HYPOGLYCEMIC AGENTS |
| NUGREL (CLOPIDOGREL BISULPHATE TABS 75MG) (3X10S) ANTI-THROMBOTICS ( WE INTENDTO CLAIM REWARDS UNDER MEIS SCHEME ) |
| I/WE UNDERTAKE TO ABIDE BY THE PROVISIONS OF FOREIGN EXCHANGE MANAGEMENT ACT 1999 AS AMENDED FROM TIME TO TIME |
| PHARMACEUTICAL PRODUCT-DAWADROXYL |
| INCLUDING REALISATION OR REPATRIATION OFFOREIGN EXCHANGE TO OR FROM INDIA |
| PHARMACEUTICAL PRODUCT-DAWADROXYL-500 |
| PHARMACEUTICAL PRODUCT-DAPODOX 200 |
| PHARMACEUTICAL PRODUCT-DAPODOX |
| PHARMACEUTICAL PRODUCT-DAPODOX 100 |
| PHARMACEUTICAL PRODUCTS:-IMICIL (IMIPENEM AND CILASTATIN FOR INJECTION USP 500 MG) |